Trial Profile
A prospective study of once-daily busulfan in conditioning regimen in patients with haematologic malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2016
Price :
$35
*
At a glance
- Drugs Busulfan (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Pharmacokinetics
- 05 Mar 2016 New trial record